Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
02/09/2012 | WO2012017925A1 Method for producing substance |
02/09/2012 | WO2012017123A1 Method for producing limited and extensive protein hydrolyzates from agroindustrial waste. |
02/09/2012 | US20120036600 Method for generating hypoallergenic glycoproteins in mutated or transgenic plants or plant cells, and mutated or transgenic plants and plant cells for generating hypoallergenic glycoproteins |
02/09/2012 | US20120036596 Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases |
02/09/2012 | US20120036590 Interferon-like protein zcyto21 |
02/09/2012 | US20120036589 Vaccine |
02/09/2012 | US20120035350 Polynucleotide encoding a novel human p2x7 splice variant, hbmyp2x7v |
02/09/2012 | US20120035110 METHOD OF PRODUCING RECOMBINANT HIGH MOLECULAR WEIGHT vWF IN CELL CULTURE |
02/09/2012 | US20120035073 Compositions and methods for the treatment of immune related diseases |
02/09/2012 | US20120034690 Cell lines producing blocking antibodies to human RANKL |
02/09/2012 | US20120034657 Thrombopoietic compounds |
02/09/2012 | US20120034656 Neutralising Antibody Molecules Having Specificity for Human IL-17 |
02/09/2012 | US20120034655 Fsh producing cell clone |
02/09/2012 | US20120034654 Method for transforming schizosaccharomyces pombe, transformant of schizosaccharomyces pombe and method for producing heterologous protein |
02/09/2012 | US20120034653 Trophic Conversion of Obligate Phototrophic Algae Through Metabolic Engineering |
02/09/2012 | US20120034652 Method for the Targeted Integration of Multiple Copies of a Gene of Interest in a Yarrowia Strain |
02/09/2012 | US20120034651 Akt activity specifically inhibiting polypeptide |
02/09/2012 | US20120034650 Nucleic acid molecule of a biosynthetic cluster encoding non ribosomal peptide synthases and uses thereof |
02/09/2012 | US20120034261 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
02/09/2012 | US20120034257 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same |
02/09/2012 | US20120034253 Influenza Vaccines, Antigens, Compositions, and Methods |
02/09/2012 | US20120034239 Proteins with improved solubility and methods for producing and using same |
02/09/2012 | US20120034237 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof |
02/09/2012 | US20120034231 Compositions and methods of use for therapeutic antibodies |
02/09/2012 | US20120034230 Cna-B DOMAIN ANTIGENS IN VACCINES AGAINST GRAM POSITIVE BACTERIA |
02/09/2012 | US20120034228 CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY |
02/09/2012 | US20120034227 Monoclonal antibody therapy for pancreas cancer |
02/09/2012 | US20120034221 T-Cell Receptor Antibodies And Methods of Use Thereof |
02/09/2012 | US20120034215 Anti-mst1r antibodies and uses thereof |
02/09/2012 | US20120034213 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
02/09/2012 | US20120034207 Production of her receptor antibodies in plant |
02/09/2012 | US20120034185 Anti-cd20 antibodies and fusion proteins therof and methods of use |
02/09/2012 | US20120034166 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof |
02/09/2012 | CA2807014A1 Dual variable domain immunoglobulins and uses thereof |
02/08/2012 | EP2415781A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and uses thereof |
02/08/2012 | EP2414384A1 Control of copolymer compositions |
02/08/2012 | EP2198037B1 Chemo-enzymatic peptide synthesis via C-terminal ester interconversion |
02/08/2012 | EP2045328B1 Peptide and nucleotide sequences of anisakis spp. and uses thereof |
02/08/2012 | EP0971958B2 Method for purifying factor viii/vwf complex by cation-exchange chromatography |
02/08/2012 | EP0805819B1 Chimeric dna-binding proteins |
02/08/2012 | CN102348807A Mono charging system for selectively introducing non-native amino acids into proteins using an in vitro protein synthesis system |
02/08/2012 | CN102348797A Novel expression vector |
02/08/2012 | CN102344900A Engineering bacterium for expressing antihypertensive peptide and method for preparing antihypertensive peptide |
02/08/2012 | CN102344493A Antibodies combined to PSCA proteins for cancer diagnosis |
02/08/2012 | CN102080064B 一种产谷氨酰胺转胺酶活化蛋白酶抑制剂的基因工程菌及其构建方法 A product by transglutaminase enzyme protease inhibitors genetically engineered bacteria and its construction method |
02/08/2012 | CN101928686B 一株分泌表面活性剂的枯草芽孢杆菌 Strain Bacillus subtilis secretion of surfactant |
02/08/2012 | CN101709321B 一种燕麦多肽及其制备方法与应用 One kind of oat peptides and preparation method and application |
02/08/2012 | CN101691406B 一种新型融合蛋白ssi、其用途及专用基因 A novel fusion protein ssi, its purpose and special genes |
02/08/2012 | CN101186940B 获得具有正确键合的胱氨酸键的胰岛素或胰岛素衍生物的方法 Cystine bonds obtained insulin or insulin derivative having correctly bonded method |
02/08/2012 | CN101153311B 菜籽低聚肽的制备方法及产品 Preparation methods and products rapeseed oligopeptide |
02/07/2012 | US8110664 Binding partners for the thyrotropin receptor and uses thereof |
02/07/2012 | US8110663 Monoclonal antibodies for cartillage oligomeric matrix protein |
02/07/2012 | US8110661 Anti-IP-10 antibodies and methods of use thereof |
02/07/2012 | US8110653 Collections of repeat proteins comprising repeat modules |
02/07/2012 | US8110549 Alpha-conotoxin peptides |
02/07/2012 | US8110546 VEGF antagonist formulations |
02/07/2012 | US8110389 Family 6 cellulase with decreased inactivation by lignin |
02/07/2012 | US8110388 Lysophosphatidic acid acyltransferase genes |
02/07/2012 | US8110382 Process for producing glycolic acid from formaldehyde and hydrogen cyanide |
02/07/2012 | US8110379 Targeted integration into the PPP1R12C locus |
02/07/2012 | US8110378 Nucleic acids encoding DCRS5 |
02/07/2012 | US8110377 HGF β chain variants |
02/07/2012 | US8110370 IBC-1 (Invasive Breast Cancer-1), a putative oncogene amplified in breast cancer |
02/07/2012 | US8110195 Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibody |
02/07/2012 | US8110192 Human immunodeficiency virus type 1 (HIV-1)-neutralizing human single-chain antibodies with improved breadth and potency |
02/07/2012 | US8110189 Using monoclonal antibody specific to biliary glycoprotein as tool in treatment and prevention of cell proliferative, autoimmune, immunodeficiency and transplant rejection disorders |
02/07/2012 | US8110187 Purification and characterization of cytotoxic lymphocyte maturation factor and monoclonal antibodies thereto |
02/07/2012 | US8110180 Method of use of cytokine ZALPHA11 ligand |
02/07/2012 | CA2382388C Fraction extracted from archaebacteria for cosmetic purposes |
02/07/2012 | CA2348971C Novel serine proteases bssp4 |
02/07/2012 | CA2328989C Serpentine transmembrane antigens expressed in human cancers and uses thereof |
02/07/2012 | CA2301964C Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses |
02/07/2012 | CA2273196C Isolated mammalian monocyte cell genes; related reagents |
02/07/2012 | CA2264484C Human plasma hyaluronidase |
02/07/2012 | CA2250381C Type c lectins |
02/02/2012 | WO2012014997A1 Anti-fdp monoclonal antibody, fdp measurement reagent and reagent kit using same, and fdp measurement method |
02/02/2012 | WO2012014996A1 Reagent and reagent kit for measurement of fdp, and measurement method |
02/02/2012 | WO2012013337A1 N-glycosylation in tranformed phaeodactylum tricornutum |
02/02/2012 | WO2011126238A3 Aboveground organ specific promoters for transforming plants and uses thereof |
02/02/2012 | US20120030839 Expression and High-Throughput Screening of Complex Expressed DNA Libraries in Filamentous Fungi |
02/02/2012 | US20120029174 Methods for producing substantially homogeneous hybrid or complex n-glycans in methylotrophic yeasts |
02/02/2012 | US20120029171 Method of Producing a Plurality of Isolated Antibodies to a Plurality of Cognate Antigens |
02/02/2012 | US20120028900 Method of producing factor viii proteins by recombinant methods |
02/02/2012 | US20120028305 Solubilization and Purification of a Target Protein Fused to a Mutant Maltose-Binding Protein |
02/02/2012 | US20120028304 Antibodies with modified isoelectric points |
02/02/2012 | US20120028303 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
02/02/2012 | US20120028302 Production of oligoclonal mixtures of immunoglobulins in single cells |
02/02/2012 | US20120028301 Somatic hypermutation systems |
02/02/2012 | US20120028300 Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof |
02/02/2012 | US20120028285 Clickable cross-linker |
02/02/2012 | US20120027858 Methods and Compositions for Managing Cancer Cell Growth |
02/02/2012 | US20120027847 Cell lines and their use in encapsulated cell biodelivery |
02/02/2012 | US20120027798 Antibody gene transfer and recombinant aav therefor |
02/02/2012 | US20120027790 Immunological herpes simplex virus antigens and methods for use thereof |
02/02/2012 | US20120027789 Antigenic peptide of hsv-2 and methods for using same |
02/02/2012 | US20120027780 Anticoagulant antidotes |
02/02/2012 | US20120027773 Anti-ron antibodies |
02/02/2012 | US20120027769 Anti-rhd monoclonal antibodies |
02/02/2012 | US20120027768 Monoclonal antibody production by ebv transformation of b cells |
02/02/2012 | CA2806399A1 Recombinantly expressed insulin polypeptides and uses thereof |